UI Investissement logo

UI Investissement

Europe, Ile-de-France, France, Paris

Description

UI Investissement is a well-established and highly active private equity firm headquartered in Paris, France, recognized for its dynamic and deeply involved approach to supporting businesses. With a robust presence across the French economic landscape, the firm positions itself as a long-term partner, committed to fostering the growth and transformation of companies at various stages of their lifecycle. Its investment philosophy emphasizes close collaboration with management teams to drive strategic development and operational improvements.

The firm employs a multi-strategy investment approach, encompassing growth capital, leveraged buyouts (LBOs), and turnaround situations, demonstrating versatility in its financial interventions. UI Investissement invests across a diverse range of sectors, including healthcare, digital technology, business services, industrial manufacturing, and food & agriculture. This broad sector focus allows them to identify and capitalize on opportunities across different market dynamics, providing tailored financial and strategic support to their portfolio companies.

UI Investissement commands significant financial firepower, managing over €1.5 billion in assets, which translates to approximately $1.62 billion USD (using an approximate exchange rate of 1 EUR = 1.08 USD). This substantial capital base enables them to execute a wide spectrum of transactions. Their extensive experience is underscored by having supported more than 300 companies since their inception, reflecting a deep commitment to the French entrepreneurial ecosystem. The typical first cheque sizes provided by UI Investissement are highly variable, reflecting their diverse investment strategies. For growth capital and regional fund initiatives, initial investments can start from approximately €1 million (around $1.08 million USD).

Conversely, for larger mid-cap and large-cap LBO transactions, their first cheques can extend significantly, reaching up to €100 million (approximately $108 million USD). This wide range of investment capabilities allows UI Investissement to serve a broad spectrum of companies, from promising SMEs seeking expansion capital to mature businesses undergoing ownership changes or requiring restructuring. Their commitment to value creation extends beyond mere capital injection, focusing on strategic guidance and operational excellence to ensure sustainable growth for their portfolio.

Investor Profile

UI Investissement has backed more than 94 startups, with 14 new investments in the last 12 months alone. The firm has led 30 rounds, about 32% of its total and boasts 11 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Private Equity, Series A, Seed rounds (top funding stages).
  • Majority of deals are located in France, Spain, Belgium.
  • Strong thematic focus on Manufacturing, Software, Health Care.
  • Typical check size: $1.1M – $108M.

Stage Focus

  • Private Equity (31%)
  • Series A (21%)
  • Seed (18%)
  • Series Unknown (17%)
  • Series B (6%)
  • Series C (2%)
  • Post Ipo Equity (2%)
  • Series D (1%)
  • Pre Seed (1%)

Country Focus

  • France (93%)
  • Spain (3%)
  • Belgium (1%)
  • Canada (1%)
  • Bulgaria (1%)

Industry Focus

  • Manufacturing
  • Software
  • Health Care
  • Biotechnology
  • Medical Device
  • Information Technology
  • Pharmaceutical
  • Medical
  • Electronics
  • Artificial Intelligence (Ai)
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does UI Investissement frequently co-invest with?

Supernova Invest
Europe, Ile-de-France, France, Paris
Co-Investments: 4
Elaia
Europe, Ile-de-France, France, Paris
Co-Investments: 4
Innovacom
Europe, Ile-de-France, France, Paris
Co-Investments: 5
GO CAPITAL
Europe, Bretagne, France, Rennes
Co-Investments: 3
KREAXI
Europe, Rhone-Alpes, France, Limonest
Co-Investments: 5
Kurma Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 4
BNP Paribas Développement
Europe, Ile-de-France, France, Paris
Co-Investments: 5
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 17
Crédit Agricole
Europe, Ile-de-France, France, Montrouge
Co-Investments: 10
BD
Europe, Ile-de-France, France, Paris
Co-Investments: 6

Which angels does UI Investissement often collaborate with?

VL
North America, Arkansas, United States, Paris
Shared Deals: 1
GA
Europe, Ile-de-France, France, Paris
Shared Deals: 1
AF
Shared Deals: 1
AM
Europe, Bourgogne, France, Dijon
Shared Deals: 1
TF
Europe, Aquitaine, France, Bordeaux
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by UI Investissement?

Fungu'it

Dijon, Bourgogne, France

A new generation of flavor ingredients for healthy, sustainable, and accessible food.

SeedJun 17, 2025
Amount Raised: $4,627,000
DeepUll

Barcelona, Catalonia, Spain

DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.

BiotechnologyLife Science
Series CApr 29, 2025
Amount Raised: $57,074,303
Fizimed

Strasbourg, Alsace, France

Fizimed is specializes in the development of connected medical devices for rehabilitation.

FitnessHealth CareSoftwareWellness
Series UnknownMar 13, 2025
Amount Raised: $4,341,955
Nova Carbon

Bordeaux, Aquitaine, France

Nova Carbon's mission is to develop a range of high performance semi-finished products made from recycled carbon fiber.

Manufacturing
SeedFeb 14, 2025
Amount Raised: $1,070,642
The QA Company

Saint Etienne, Rhone-Alpes, France

The QA Company is an AI platform that boosts productivity by optimizing knowledge management and supporting decision-making.

Data IntegrationMachine Learning
Series AFeb 7, 2025
Amount Raised: $2,892,819
Laclarée

Lyon, Rhone-Alpes, France

Laclarée develops a pair of adaptive eyeglasses for presbyopia.

Eyewear
SeedJan 28, 2025
Amount Raised: $3,649,563
Quibim

Valencia, Comunidad Valenciana, Spain

Quibim is a radiomics company specializing in quantitative imaging of biomarkers and medical applications in precision medicine.

Artificial Intelligence (AI)BiotechnologyClinical TrialsHealth CareHealth Diagnostics
Series AJan 28, 2025
Amount Raised: $50,000,000
Coave Therapeutics

Paris, Ile-de-France, France

Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.

BiotechnologyGeneticsLife ScienceNeuroscience
Series AJan 9, 2025
Amount Raised: $32,948,556
AdEchoTech

Naveil, Centre, France

AdEchoTech is specialized in tele-ultrasound with a robotic solution named MELODY.

FitnessHealth CareMedicalMedical DeviceRobotics
Series UnknownOct 9, 2024
Amount Raised: $4,376,660
Ultrawatt

Lyon, Rhone-Alpes, France

Ultrawatt is a mission-driven startup to improve urban architecture while making a beneficial social and environmental effect.

ArchitectureConstruction
SeedOct 4, 2024
Amount Raised: $2,196,101